EGFR and lung carcinoma: The inhibitory effect of ABL kinase inhibition on MMP9 secretion is selective because loss of ABL function did not impair secretion of other MMPs or the EGFR ligand amphiregulin (AREG), which is induced by MSC-priming in lung cancer cells.